2015
DOI: 10.1016/j.clinph.2014.12.024
|View full text |Cite
|
Sign up to set email alerts
|

The P3a wave: A reliable neurophysiological measure of Parkinson’s disease duration and severity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
60
2
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(72 citation statements)
references
References 59 publications
9
60
2
1
Order By: Relevance
“…Another recent finding that underscores the functional relevance of P3a in PD has been reported by Solís-Vivanco et al (2015). These authors found the degree of P3a amplitude attenuation in 55 PD patients to be linearly related to disease duration, even when controlling for covariates such as age and MMSE score.…”
Section: P3b In Pd: Conclusion and Future Directionsmentioning
confidence: 71%
See 2 more Smart Citations
“…Another recent finding that underscores the functional relevance of P3a in PD has been reported by Solís-Vivanco et al (2015). These authors found the degree of P3a amplitude attenuation in 55 PD patients to be linearly related to disease duration, even when controlling for covariates such as age and MMSE score.…”
Section: P3b In Pd: Conclusion and Future Directionsmentioning
confidence: 71%
“…These authors found the degree of P3a amplitude attenuation in 55 PD patients to be linearly related to disease duration, even when controlling for covariates such as age and MMSE score. This finding has been suggested to indicate that P3a amplitude may qualify as a reliable biomarker of disease progression (Solís-Vivanco et al, 2015).…”
Section: P3b In Pd: Conclusion and Future Directionsmentioning
confidence: 78%
See 1 more Smart Citation
“…Future research may further examine how N e /ERN amplitudes relate to the clinical and psychological profile of PD patients and determine its usefulness as a marker, e.g., for disease progression or for the development of non-motor symptoms, such as depression or executive dysfunction. ERP measures have already been proposed to be promising in this respect, both in Parkinson’s disease4243 and in other neurological disorders4445464748, where motor symptoms are likely to distort the results of other imaging techniques or neuropsychological testing.…”
Section: Discussionmentioning
confidence: 99%
“…Also further analysis on the ERP data showed that in our sample, burnout severity was not sufficient to predict the amount of attenuation of the P3 response. responses in a simple target detection task (Knight, 1997), and Parkinson's disease showing decreased auditory P3a responses (Solís-Vivanco et al, 2015).…”
Section: Discussionmentioning
confidence: 99%